VEGFA and cancer: Depending on the differences in pathogenesis, clinical manifestations, and prognostic characteristics, TMA induced by anti-cancer drugs is divided into type I TMA, which is related to the direct endothelial toxicity of chemotherapy drugs, and type II TMA, caused by anti-vascular endothelial growth factor (VEGF) drugs [4–6].